Related Experiment Video
Updated: Apr 27, 2026

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
Published on: August 30, 2024
Arrhythmias in structural heart disease
H Sawyer Gillespie1, Charles C H Lin, Jordan M Prutkin
1Division of Cardiology, University of Washington, 1959 NE Pacific Street, Box 356422, Seattle, WA, 98195, USA.
Insights
Structural heart disease often causes electrical heart abnormalities like arrhythmias. Treatment focuses on the underlying cause and may include medications, pacemakers, or implantable cardioverter-defibrillators (ICDs) to manage risks.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Structural heart disease is frequently linked to cardiac electrical abnormalities, specifically atrial and ventricular arrhythmias.
- These arrhythmias can arise in patients with various conditions, including ischemic and non-ischemic cardiomyopathies, congenital heart disease, and other myocardial structural issues.
Purpose of the Study:
- To outline the management strategies for arrhythmias associated with structural heart disease.
- To emphasize the role of implantable cardioverter-defibrillators (ICDs) in managing life-threatening arrhythmias.
Main Methods:
- Review of current therapeutic approaches for arrhythmias in structural heart disease.
- Discussion of medical therapies, device-based interventions (pacemakers, ICDs), and ablation techniques.
- Emphasis on patient selection and device choice for ICD therapy.
Main Results:
- Treatment prioritizes addressing the underlying structural heart disorder through interventions like surgery or catheter-based procedures.
- Pharmacological agents (beta-blockers, anti-arrhythmics), pacemakers, ICDs, and ablation are employed for prophylaxis or treatment.
- ICDs are crucial for patients at risk of malignant arrhythmias, with careful selection vital for outcomes.
Conclusions:
- Arrhythmias in structural heart disease require a multifaceted treatment approach, often beginning with addressing the primary cardiac abnormality.
- Device selection and patient management are critical for optimizing the efficacy and safety of interventions like ICDs.
- Therapeutic decisions, including prophylactic measures, are made based on arrhythmia risk and potential for adverse events, irrespective of symptom presence.
Abstract:
The presence of structural heart disease is often associated with the development of electrical abnormalities of the heart, manifesting as atrial and ventricular arrhythmias. These can occur in those with ischemic and nonischemic cardiomyopathies, congenital heart disease, and various acquired and intrinsic structural abnormalities of the myocardium. Treatment of these arrhythmias generally involves treatment of the underlying disorder first, if possible, such as with surgical or catheter-based intervention. Other therapies, including medical therapy with beta-blockers and anti-arrhythmic agents, pacemakers and implantable cardioverter-defibrillators (ICDs), and ablation may be offered both as prophylactic therapy or if arrhythmias have developed. In some instances, therapy is undertaken regardless of whether there are symptoms. ICDs provide support for those patients at risk for malignant, life-threatening arrhythmias, but appropriate patient and device selection are vital to improve mortality and to limit adverse events.
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Mechanism of Cardiac Arrhythmias
Dysrhythmias I: Introduction
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Dysrhythmias V: Evaluating Dysrhythmias

